0001209191-21-049605.txt : 20210804 0001209191-21-049605.hdr.sgml : 20210804 20210804160957 ACCESSION NUMBER: 0001209191-21-049605 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210802 FILED AS OF DATE: 20210804 DATE AS OF CHANGE: 20210804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Andrews William T. CENTRAL INDEX KEY: 0001638459 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36287 FILM NUMBER: 211144081 MAIL ADDRESS: STREET 1: ONE MAIN STREET, SUITE 800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Flexion Therapeutics Inc CENTRAL INDEX KEY: 0001419600 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: (781) 305-7777 MAIL ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-02 0 0001419600 Flexion Therapeutics Inc FLXN 0001638459 Andrews William T. C/O FLEXION THERAPEUTICS, INC. 10 MALL ROAD, SUITE 301 BURLINGTON MA 01803 0 1 0 0 Chief Medical Officer Common Stock 2021-08-02 4 A 0 34250 0.00 A 34250 D Stock option (right to buy) 6.25 2021-08-02 4 A 0 205500 0.00 A 2031-08-01 Common Stock 205500 205500 D Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan. 25% of the shares subject to the option shall vest on the one-year anniversary of July 1, 2021 (the "Vesting Commencement Date"), and 1/48th of the shares subject to the option shall vest each month following the one-year anniversary of the Vesting Commencement Date, so that all of the shares subject to the options shall be vested four years after the Vesting Commencement Date. /s/ Mark S. Levine, Attorney-in-Fact 2021-08-04